Exploring indirect sources of human exposure to perfluoroalkyl carboxylates (PFCAs): Evaluating uptake, elimination, and biotransformation of polyfluoroalkyl phosphate esters (PAPs) in the Rat

Environmental Health Perspectives

Volumn 119, Issue 3, 2011, Pages 344-350

  D'eon, Jessica C ^a   Mabury, Scott A ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Biotransformation; Human exposure; Perfluorinated carboxylates; Perfluorooctanoic acid; Pharmacokinetics; Polyfluoroalkyl phosphate esters

Indexed keywords

CARBOXYLIC ACID DERIVATIVE; ORGANOPHOSPHATE; PERFLUORO COMPOUND; PERFLUOROOCTANOIC ACID;

ANIMAL EXPERIMENT; ARTICLE; BIOAVAILABILITY; BIOTRANSFORMATION; BLOOD LEVEL; CONTROLLED STUDY; EXPOSURE; FECES LEVEL; INTESTINE ABSORPTION; MALE; NONHUMAN; PLASMA HALF LIFE; PREDICTION; PRIORITY JOURNAL; RAT; TOXICOKINETICS; TRANSPORT KINETICS; URINE LEVEL;

ANIMALS; BIOTRANSFORMATION; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL POLLUTANTS; ESTERS; FECES; FLUOROCARBONS; HUMANS; MALE; PHOSPHATES; RATS; RATS, SPRAGUE-DAWLEY;

ANIMALIA; RATTUS;

EID: 79952323654     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.1002409     Document Type: Article

References (37)

1. 3M. 2000. Phase-out Plan for POSF-Based Products. U.S. EPA (Environmental Protection Agency) Docket OPPT-2002-0043. St. Paul, MN:3M, Specialty Materials Markets Group.
2. Andersen ME, Butenhoff JL, Chang S-C, Farrar DG, Kennedy GL Jr, Lau C, et al. 2008. Perfluoroalkyl acids and related chemistries-toxicokinetics and modes of action. Toxicol Sci 102:3-14.
3. Begley TH, Hsu W, Noonan G, Diachenko G. 2008. Migration of fluorochemical paper additives from food-contact paper into foods and food simulants. Food Add Contam 25:384-390.
4. Benskin JP, De Silva AO, Martin LJ, Arsenault G, McCrindle R, Riddell N, et al. 2009. Disposition of perfluorinated acid isomers in Sprague-Dawley rats; part 1: single dose. Environ Toxicol Chem 28:542-554.
5. Butt CM, Muir DCG, Mabury SA. 2010. Biotransformation of the 8:2 fluorotelomer acrylate in rainbow trout. I. In vivo dietary exposure. Environ Toxicol Chem 29(12):2726-2735.
6. Calafat AM, Wong L-Y, Kuklenyik Z, Reidy JA, Needham LL. 2007. Polyfluoroalkyl chemicals in the U.S. population: data from the National Health and Nutrition Examination Survey (NHANES) 2003-2004 and comparisons with NHANES 1999-2000. Environ Health Perspect 115:1596-1602.
7. Chang S-C, Das K, Ehresman DJ, Ellefson ME, Gorman GS, Hart JA, et al. 2008. Comparative pharmacokinetics of perfluorobutyrate in rats, mice, monkeys, and humans and relevance to human exposure via drinking water. Toxicol Sci 104:40-53.
8. D'eon JC, Crozier PW, Furdui VI, Reiner EJ, Libelo EL, Mabury SA. 2009. Observation of a commercial fluorinated material, the polyfluoroalkyl phosphoric acid diesters, in human sera, wastewater treatment plant sludge, and paper fibers. Environ Sci Technol 43:4589-4594.
9. D'eon JC, Mabury SA. 2007. Production of perfluorinated carboxylic acids (PFCAs) from the biotransformation of polyfluoroalkyl phosphate surfactants (PAPS): exploring routes of human contamination. Environ Sci Technol 41:4799-4805.
10. D'eon JC, Mabury SA. 2010. Uptake and elimination of perfluorinated phosphonic acids in the rat. Environ Toxicol Chem 29:1319-1329.
11. De Silva AO, Benskin JP, Martin LJ, Arsenault G, McCrindle R, Riddell N, et al. 2009. Disposition of perfluorinated acid isomers in Sprague-Dawley rats; part 2: subchronic dose. Environ Toxicol Chem 28:555-567.
12. De Silva AO, Mabury SA. 2006. Isomer distribution of perfluorocarboxylates in human blood: potential correlation to source. Environ Sci Technol 40:2903-2909.
13. DuPont. 2002. Telomer Research Program Update. Presentation to the U.S. EPA, November 25, 2002. Public Docket AR226-1141. Washington, DC:U.S. Environmental Protection Agency Office of Pullution Prevention and Toxics. Available: http://www.regulations.gov/#!documentDetail;D=EPA-HQ-OPPT-2002-0051-0034 [accessed 25 January 2011].
14. Dupont. 2005. DuPont Global PFOA Strategy. Presentation to the U.S. EPA, January 31, 2005. Public Docket AR226-1914. Washington, DC:U.S. Environmental Protection Agency Office of Pullution Prevention and Toxics.
15. Fasano WJ, Carpenter SC, Gannon SA, Snow TA, Stadler JC, Kennedy GL Jr, et al. 2006. Absorption, distribution, metabolism, and elimination of 8-2 fluorotelomer alcohol in the rat. Toxicol Sci 91:341-355.
16. Fromme H, Schlummer M, Möller A, Gruber L, Wolz G, Ungewiss J, et al. 2007. Exposure of an adult population to perfluorinated substances using duplicate diet portions and biomonitoring data. Environ Sci Technol 41:7928-7933.
17. Fromme H, Tittlemier SA, Völkel W, Wilhelm M, Twardella D. 2009. Perfluorinated compounds-exposure assessment for the general population in western countries. Int J Hyg Environ Health 212:239-270.
18. Hagen DF, Belisle J, Johnson JD, Venkateswarlu P. 1981. Characterization of fluorinated metabolites by a gas chromatographic-helium microwave plasma detector-the biotransformation of 1H,1H,2H,2H-perfluorodecanol to perfluorooctanoate. Anal Biochem 118:336-343.
19. Han X, Yang C-H, Snajdr SI, Nabb DL, Mingoia RT. 2008. Uptake of perfluorooctanoate in freshly isolated hepatocytes from male and female rats. Toxicol Lett 181:81-86.
20. Haug LS, Thomsen C, Becher G. 2009. Time trends and the influence of age and gender on serum concentrations of perfluorinated compounds in archived human samples. Environ Sci Technol 43:2131-2136.
21. Kärrman A, Harada KH, Inoue K, Takasuga T, Ohi E, Koizumi A. 2009. Relationship between dietary exposure and serum perfluorochemical (PFC) levels-a case study. Environ Int 35:712-717.
22. Kärrman A, Mueller JF, Van Bavel B, Harden F, Toms L-ML, Lindström G. 2006. Levels of 12 perfluorinated chemcials in pooled Australian serum, collected 2002-2003, in relation to age, gender, and region. Environ Sci Technol 40:3742-3748.
23. Kissa E. 2002. Fluorinated Surfactants. New York:Marcel Dekker.
24. Lee H, D'eon J, Mabury SA. 2010. Biodegradation of polyfluoroalkyl phosphates (PAPs) as a source of perfluorinated acids to the environment. Environ Sci Technol 44:3305-3310.
25. Ohmori K, Kudo N, Katayama K, Kawashima Y. 2003. Comparison of the toxicokinetics between perfluorocarboxylic acids with different carbon chain length. Toxicology 184:135-140.
26. Olsen GW, Burris JM, Ehresman DJ, Froehlich JW, Seacat AM, Butenhoff JL, et al. 2007. Half-life and serum elimination of perfluorooctanesulfonate, perfluorohexanesulfonate, and pefluorooctanoate in retired fluorochemical production workers. Environ Health Perspect 115:1298-1305.
27. Olsen GW, Huang H-Y, Helzlsouzer KJ, Hansen KJ, Butenhoff JL, Mandel JH. 2005. Historical comparison of perfluorooctanesulfonate, perfluorooctanoate, and other fluorochemicals in human blood. Environ Health Perspect 113:539-545.
28. Olsen GW, Mair DC, Church TR, Ellefson ME, Reagen WK, Boyd TM, et al. 2008. Decline in perfluorooctanesulonate and other polyfluoroalkyl chemicals in American Red Cross adult blood donors, 2000-2006. Environ Sci Technol 42:4989-4995.
29. Ostertag SK, Chan HM, Moisey J, Dabeka R, Tittlemier SA. 2009. Historic dietary exposure to perfluorooctane sulfonate, perfluorinated carboxylates, and fluorotelomer unsaturated carboxylates from the consumption of store-bought and restaurant foods for the Canadian population. J Agric Food Chem 57:8534-8544.
30. Shoeib M, Harner T, Wilford B, Jones KC, Zhu J. 2005. Perfluorinated sulfonamides in indoor and outdoor air and indoor dust: occurrence, partitioning, and human exposure. Environ Sci Technol 39:6599-6606.
31. Stock NL, Lau FK, Ellis DA, Martin JW, Muir DDC, Mabury SA. 2004. Polyfluorinated telomer alcohols and sulfonamides in the North American troposphere. Environ Sci Technol 38:991-996.
32. Trudel D, Horowitz L, Wormuth M, Scheringer M, Cousins IT, Hungerbuhler K. 2008. Estimating consumer exposure to PFOS and PFOA. Risk Anal 28:251-269.
33. Vestergren R, Cousins IT. 2009. Tracking the pathways of human exposure to perfluorocarboxylates. Environ Sci Technol 43:5565-5575.
34. Vestergren R, Cousins IT, Trudel D, Wormuth M, Scheringer M. 2008. Estimating the contribution of precursor compounds in consumer exposure to PFOS and PFOA. Chemosphere 73:1617-1624.
35. Ward KW, Hardy LB, Kehler JR, Azzarano M, Smith BR. 2004. Apparent absolute oral bioavailability in excess of 100% for a vitronectin receptor antagonist (SB-265123) in rat. II. Studies implicating transporter-mediated intestinal secretion. Xenobiotica 34:367-377.
36. Xu L, Krenitsky DM, Seacat AM, Butenhoff JL, Anders MW. 2004. Biotransformation of N-ethyl-N-(2-hydroxyethyl)perfluorooctanesulfonamide by rat liver microsomes, cytosol, and slices and by expressed rat and human cytochromes P450. Chem Res Toxicol 17:767-775.
37. Yamashita N, Kannan K, Taniyasu S, Horii Y, Petrick G, Gamo T. 2005. A global survey of perfluorinated acids in oceans. Mar Pollut Bull 51:658-668.